Invest in Scientists, Not Just Science, for Breakthroughs

Scientific advancement hinges on the patient, dedicated work of researchers, yet societal focus often centers on tangible breakthroughs rather than the arduous process that enables them. This is particularly true for early-career scientists, who face pressure to produce research easily articulated in grant applications with clear deliverables, potentially stifling more abstract or unconventional lines of inquiry.

Major scientific discoveries, from the material graphene to new medical treatments, often arise from serendipity, imagination, and the curiosity of scientists to recognize their significance. These breakthroughs frequently emerge from tangential research or unexpected avenues, demonstrating that science is less a linear path to a known destination and more an evolving exercise in exploration.

Institutional funding bodies and universities grapple with selecting which projects to support before their ultimate direction is known. With limited resources and many scientists competing for them, promising research can be lost. Philanthropy can play a crucial role in broadening support for young scientists, especially through unrestricted funding.

Unrestricted funding represents an investment in the scientist themselves—their talent, judgment, curiosity, and potential. This financial freedom allows for the purchase of new equipment, hiring staff, or pursuing novel ideas that might be too abstract for conventional grant applications. It provides the mental space and time necessary for deep thinking, alleviating financial pressures and enabling scientists to focus on their work.

The Blavatnik Awards for Young Scientists exemplify this principle, offering grants of $15,000 to $250,000 with no attached conditions, empowering awardees to direct funds where they can make the greatest impact on their research. These awards recognize that the freedom to explore, experiment, and persevere is fundamental to scientific progress.

While philanthropy cannot replace institutional or government funding, it can foster an environment conducive to greater risk-taking and unexpected discoveries. It aids in retaining exceptional scientific talent and driving innovation. The success of past Blavatnik Award recipients, who have founded companies valued in the tens of billions of dollars, underscores the potential of investing in scientists directly. These successes range from battery technology and gene editing to novel cancer treatments, demonstrating the broad impact of empowered scientific exploration.